Literature DB >> 3005466

Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.

M Rodriguez, J Leibowitz, C S David.   

Abstract

Demyelination induced by Theiler's virus was examined in mouse strains with congeneic recombinant haplotypes. Light and electron microscopy of spinal cord sections from mice with s, q, v, p, and f H-2D alleles showed perivascular inflammation and primary demyelination. The presence of susceptible haplotypes in the K or I region did not correlate with pathologic abnormalities. The Qa, Tla, PgK, and UpG genes did not appear to be critical in determining susceptibility to disease. However, mutation in the H-2D genes altered the susceptibility to virus-induced demyelination. B10.D2dm1 mice, which have deletions in the 3' end of Dd and the 5' end of Ld, showed prominent demyelination and clinical deficits. In contrast, BALB/c-dm2, which have a deletion of the entire L gene, showed no pathologic changes. Central nervous system virus titers correlated with susceptibility to demyelination; both resistant and susceptible strains had a strong humoral immune response to the virus. The findings in the congeneic recombinant mice and in mice mutant in the H-2D region strongly suggest that at least one of the genes critical for determining virus-induced demyelination maps to the 3' end of the H-2D gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005466      PMCID: PMC2188055          DOI: 10.1084/jem.163.3.620

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease. The pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE.

Authors:  R L Barbano; M C Dal Canto
Journal:  J Neurol Sci       Date:  1984 Nov-Dec       Impact factor: 3.181

2.  Possible role of regulatory genes in H-2D-end immune functions.

Authors:  S K Singh; C S David
Journal:  Transplant Proc       Date:  1983-12       Impact factor: 1.066

3.  A molecular hybrid of the H-2Dd and H-2Ld genes expressed in the dm1 mutant.

Authors:  S S Burnside; P Hunt; K Ozato; D W Sears
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 4.  Biochemistry of the gene products from murine MHC mutants.

Authors:  R Nairn; K Yamaga; S G Nathenson
Journal:  Annu Rev Genet       Date:  1980       Impact factor: 16.830

5.  Rfv-1 and Rfv-2, two H-2-associated genes that influence recovery from Friend leukemia virus-induced splenomegaly.

Authors:  B Chesebro; K Wehrly
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

6.  Demyelination induced by Theiler's virus: influence of the H-2 haplotype.

Authors:  M Rodriguez; C S David
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

7.  Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.

Authors:  M Rodriguez; J L Leibowitz; P W Lampert
Journal:  Ann Neurol       Date:  1983-04       Impact factor: 10.422

8.  Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction.

Authors:  H M Wisniewski; B R Bloom
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

9.  SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE.

Authors:  M Theiler
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

10.  Observations on encephalomyelitis of mice (DA strain).

Authors:  J B DANIELS; A M PAPPENHEIMER; S RICHARDSON
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

View more
  83 in total

1.  Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination.

Authors:  D B McGavern; L Zoecklein; K M Drescher; M Rodriguez
Journal:  Exp Neurol       Date:  1999-07       Impact factor: 5.330

2.  Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.

Authors:  A J Johnson; M K Njenga; M J Hansen; S T Kuhns; L Chen; M Rodriguez; L R Pease
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Viral load increases in SJL/J mice persistently infected by Theiler's virus after inactivation of the beta(2)m gene.

Authors:  S Aubagnac; M Brahic; J F Bureau
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Epitope-tagged L* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection.

Authors:  Kunihiko Asakura; Harunobu Murayama; Toshiki Himeda; Yoshiro Ohara
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Authors:  Fumitaka Sato; Hiroki Tanaka; Faris Hasanovic; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2011-02

7.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice.

Authors:  R L Yauch; K Kerekes; K Saujani; B S Kim
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.

Authors:  A Azoulay; M Brahic; J F Bureau
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Interleukin-6 protects anterior horn neurons from lethal virus-induced injury.

Authors:  Kevin D Pavelko; Charles L Howe; Kristen M Drescher; Jeff D Gamez; Aaron J Johnson; Tao Wei; Richard M Ransohoff; Moses Rodriguez
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.